Novonco Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $11M

  • Investors
  • 1

Novonco Therapeutics General Information

Description

Developer of novel small molecule therapies and medicines designed to treat solid and hematologic cancers. The company's pipeline consists of small molecule inhibitors of ribonucleotide reductase and DNA repair, epigenetic therapy with the potential to treat pancreatic cancer, and a new class of selective kinase inhibitors for personalized medicine in molecularly-targeted therapeutics, enabling patients to get personalized cancer treatment.

Contact Information

Formerly Known As
Novonco Therapeutics Inc
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12100 Wilshire Boulevard
  • Suite 800
  • Los Angeles, CA 90025
  • United States
+1 (310)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 12100 Wilshire Boulevard
  • Suite 800
  • Los Angeles, CA 90025
  • United States
+1 (310)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novonco Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 18-Feb-2020 $11M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) Completed Clinical Trials - Phase 1
To view Novonco Therapeutics’s complete valuation and funding history, request access »

Novonco Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Novonco Therapeutics’s complete cap table history, request access »

Novonco Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel small molecule therapies and medicines designed to treat solid and hematologic cancers. The company's
Drug Discovery
Los Angeles, CA

Foster City, CA
 

Thousand Oaks, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novonco Therapeutics Competitors (7)

One of Novonco Therapeutics’s 7 competitors is Gilead, a Formerly VC-backed company based in Foster City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gilead Formerly VC-backed Foster City, CA
Amgen Formerly PE-Backed Thousand Oaks, CA
Panbela Therapeutics Formerly VC-backed Waconia, MN
Aura Biosciences Formerly VC-backed Boston, MA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
You’re viewing 5 of 7 competitors. Get the full list »

Novonco Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Multiverse Investment Venture Capital Minority
To view Novonco Therapeutics’s complete investors history, request access »

Novonco Therapeutics FAQs

  • When was Novonco Therapeutics founded?

    Novonco Therapeutics was founded in 2014.

  • Where is Novonco Therapeutics headquartered?

    Novonco Therapeutics is headquartered in Los Angeles, CA.

  • What industry is Novonco Therapeutics in?

    Novonco Therapeutics’s primary industry is Drug Discovery.

  • Is Novonco Therapeutics a private or public company?

    Novonco Therapeutics is a Private company.

  • What is the current valuation of Novonco Therapeutics?

    The current valuation of Novonco Therapeutics is .

  • What is Novonco Therapeutics’s current revenue?

    The current revenue for Novonco Therapeutics is .

  • How much funding has Novonco Therapeutics raised over time?

    Novonco Therapeutics has raised $14M.

  • Who are Novonco Therapeutics’s investors?

    Multiverse Investment has invested in Novonco Therapeutics.

  • Who are Novonco Therapeutics’s competitors?

    Gilead, Amgen, Panbela Therapeutics, Aura Biosciences, and Genetix Biotherapeutics are some of the 7 competitors of Novonco Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process